ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Suzanne Fuqua on the Interaction Between ER and AR

Suzanne A. W. Fuqua, PhD
Published: Thursday, Sep 12, 2013

Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, talks about the interaction between estrogen receptors (ER) and androgen receptors (AR) in patients with breast cancer.

Fuqua says receptors, like AR and ER, can bind together at non-genomic sites and elicit one effect, like protein kinase B/Akt. Receptors can also bind together on DNA to help regulate genes, which cause proliferation, Fuqua says.

The basic biology is becoming clear that receptors are acting together, Fuqua says, raising the need for combination therapies when treating patients with breast cancer.

Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, talks about the interaction between estrogen receptors (ER) and androgen receptors (AR) in patients with breast cancer.

Fuqua says receptors, like AR and ER, can bind together at non-genomic sites and elicit one effect, like protein kinase B/Akt. Receptors can also bind together on DNA to help regulate genes, which cause proliferation, Fuqua says.

The basic biology is becoming clear that receptors are acting together, Fuqua says, raising the need for combination therapies when treating patients with breast cancer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x